Sweden, June 1 -- Sweden based Purpose Pharma International AB has secured contract from Vergabekammer des Bundes beim Bundeskartellamt for Pharmaceutical products - Announcement of orders awarded in accordance with Section 130 a Paragraph 8 SGB V and Section 130 c SGB V for the preparation with the active ingredient Diflunisal Attrogy . The value of the contract is not disclosed .
Published by HT Digital Content Services with permission from Pivotal Sources....